Lifecore Biomedical, Inc. De (LFCR) Research & Development (2010 - 2025)

Lifecore Biomedical's Research & Development history runs 16 years deep, the most recent figure standing at $2.1 million for Q2 2025.

• In Q2 2025, Research & Development fell 2.68% year-over-year to $2.1 million; the TTM figure through May 2025 stood at $8.3 million (down 3.7% YoY), while the FY2025 annual figure was $8.3 million, down 3.7% from the prior year.
• Research & Development was $2.1 million for Q2 2025 at Lifecore Biomedical, up from $2.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $7.8 million in Q2 2022 to a low of $1.6 million in Q1 2021.
• Historically, Research & Development has averaged $2.6 million across 5 years, with a median of $2.2 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Research & Development soared 927.23% in 2021, then sank 72.74% in 2023.
• A 5-year view of Research & Development shows it stood at $1.7 million in 2021, then increased by 29.58% to $2.2 million in 2022, then fell by 3.63% to $2.1 million in 2023, then declined by 8.29% to $1.9 million in 2024, then increased by 9.3% to $2.1 million in 2025.
• The last three Research & Development figures came in at $2.1 million (Q2 2025), $2.0 million (Q1 2025), and $1.9 million (Q4 2024), per Business Quant data.